| MATERIALS AND METHODS

| Subjects
From February to May 2012, at Zhongshan Hospital affiliated with Sun Yat-sen University, we enrolled two patients from the healthcare center, two patients who had come for pregnancy check-ups at the women's health center, and one inpatient from the endocrinology department. There were two men and three women; the age range was 20-45 years. The HbA1c test results and blood glucose results were inconsistent in all five subjects. This study was conducted in accordance with the declaration of Helsinki. This study was conducted with approval from the Ethics Committee of Zhongshan Hospital Affiliated to Sun Yat-sen University. Written informed consent was obtained from all participants.
| Test methods
The VARIANT II Turbo analyzer (Bio-Rad Laboratories, Hercules, CA, USA) uses IE-HPLC for quantification of HbA1c. The Primus Ultra 2 analyzer is based on boronate affinity HPLC (BA-HPLC). These are routine methods used for measuring HbA1c in our laboratory.
The Modular PPI analyzer (Roche Diagnostics GmbH, Mannheim, Germany) quantifies HbA1c using TINIA and uses hexokinase to assess the levels of plasma glucose. The TINIA commercial kit is a thirdgeneration immunoassay in which the epitope of the antibody spans 1-4th amino acids near the N-terminal of the HbA β-chain.
The Capillarys Analyzer (Sebia Lisses, France) is used for the identification and levels of Hb variants such as Hb J Bankok, HbE, Hb G Taipei, and HbH. The Applied Biosystems 3730xl sequencer (Applied Biosystems, Foster City, CA, USA) uses dideoxy-mediated chain termination (Sanger method) for sequencing genes that encode Hb. The average levels of fasting plasma glucose were calculated using two or three measurements of fasting plasma glucose; plasma was collected from patients from February to May 2012. eAG (estimated average glucose) was calculated according to the equation recommended by NGSP::eAG(mg/ dL)=(28.7*HbA1c)-46.7 or eAG(mmol/L)=(1.59*HbA1c)-2.59.
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| Statistical analysis
Data were analyzed using Microsoft Excel and SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). The Kolmogorov-Smirnov test was used to determine whether one-sample test analysis data conformed to a normal distribution. Differences between normally distributed groups were analyzed using the paired t test; a value of P<.05 was assumed to denote statistical significance. Data were expressed as mean±standard deviation (x±s).
| RESULTS
| Phenotype
Results of the five Results of phenotype detection in the five subjects were shown in Table 1 
| Hb electrophoresis
Hb electrophoresis was used to characterize the Hb variants and to assess the potential to interfere with analysis using IE-HPLC. The results of Hb electrophoresis were aberrant in four patients; one patient an anomalous peak in the Z12 zone (93.9% of the zone), and the rest was HbA (1.0%) and HbA2 (5.1%); there was almost no HbA, whereas the HbA2 level was higher than normal ( Figure 2A ). In the second patient, an anomalous peak was observed in the Z12 zone (52.4% of the zone), whereas 44.6% of the peaks were from HbA and 2.4% were from HbA2; compared with normal levels, the level of HbA was lower, whereas that of HbA2 was elevated ( Figure 2B ). In the third patient, HbE was detected at 23.6%, HbA at 72.7%, and HbA2 at 3.7% ( Figure 2C ). In the fourth patient, an anomalous peak was observed in the Z6 zone (39.5% of the zone), whereas HbA was detected at 56.9% and HbA2 at 3.5%
( Figure 2D ). The fifth patient had an elevated level of HbA at 89.9%, whereas that of HbA2 was at 0.9%; this patient also showed anomalous peaks in zones Z15 and Z12, indicating that the levels of HbH and Hb Bart's were at 6.1% and 2.8%, respectively ( Figure 2E ).
| Gene sequencing
To determine the types of Hb variants, we performed gene sequencing using the Sanger method. Four subjects had Hb β-chain gene mutations. Among them, one subject had a point mutation in codon 56 (GGC>GAC) of the gene, and carried the β41-42 (-TCTT) deletion associated with β-thalassemia, and the Hb genotype was β 41-42 / β J Bangkok , i.e., the subject had β-thalassemia combined with the HbJ Figure 3A ), which was identified as an HbJ Bangkok heterozygote.
The third subject had a point mutation in codon 26 (Glu→Lys) of the gene, and the Hb genotype was β N /β E , which we confirmed as an HbE heterozygote. The fourth subject had a point mutation in codon 22
(Glu>Gly) of the gene, and the Hb genotype was β N /β G Taipei , which we confirmed as an HbG Taipei heterozygote ( Figure 3B) . The results are shown in Table 2 .
In this study, the genotype of the first patient was The genotype of the third patient was β N /β E Hb, indicating an HbE heterozygote. HbE, the second most common aberrant Hb, is caused by substitution of glutamate (Glu) with lysine (Lys) in codon 26 of the β-globin gene, causing an Hb dysfunction similar to β-thalassemia.
The HbE heterozygote has no clinical manifestations. 22 The results of HbA1c analysis using IE-HPLC for this patient indicated a slightly lagging RT; therefore, HbA0 was misidentified as the variant, and HbE was misidentified as HbA0, leading to falsely elevated HbA1c content.
The genotype of the fourth patient was β N /β G Taipei Hb, representing a HbG Taipei heterozygote. HbG Taipei is an aberrant Hb;
HbG is distributed worldwide, whereas HbG Chinese and HbG Taipei occur only in China. 23 A point mutation in codon 22 of the β-globin gene causes the substitution of Glu with Gly. The results of HbA1c analysis using IE-HPLC for this patient showed a longer RT than that of HbA0 because the point mutation in the globin chain increases the positive charge of the globin chain. Because this patient was an Hb heterozygote, the separated peak shape was anomalous and no normal HbA0 was identified, leading to the highly elevated content of HbA1c.
The fifth patient tested negative for β-thalassemia. 
